Antidepressant Efficacy of Escitalopram in Major Depressive Disorder

  • Kirino E
N/ACitations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Escitalopram (escitalopram oxalate; Cipralex®, Lexapro®) is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of major depressive disorder (MDD) and anxiety disorder. This drug exerts a highly selective, potent, and dose-dependent inhibitory effect on the human serotonin transport. By inhibiting the reuptake of serotonin into presynaptic nerve endings, this drug enhances the activity of serotonin in the central nervous system. Escitalopram also has allosteric activity. Moreover, the possibility of interacting with other drugs is considered low.

Cite

CITATION STYLE

APA

Kirino, E. (2016). Antidepressant Efficacy of Escitalopram in Major Depressive Disorder. In Melatonin, Neuroprotective Agents and Antidepressant Therapy (pp. 465–476). Springer India. https://doi.org/10.1007/978-81-322-2803-5_30

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free